IP Library Patent Application 11419688
Patent Application
App. No. 11/419,688

ANTIBODIES SPECIFIC FOR UNGULATE PrP

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/419,688
Abstract

The present invention provides antibodies that specifically bind with a high degree of binding affinity to a native ungulate PrP C and/or a denatured ungulate PrP Sc , but not to a native ungulate PrP Sc . Preferred antibodies find native bovine PrP C and treated PrP Sc but not native bovine PrP Sc and can be used in an assay to determine if a sample is infected with infectious prions, i.e. PrP Sc .

Claims (35)

1 .- 20 . (canceled)

21 . A method of detecting PrP Sc in a sample, comprising the steps of:

treating a sample obtained from an ungulate to denature PrP Sc in the sample;

contacting the sample with a labeled antibody characterized by its ability to bind to denatured ungulate PrP Sc and native ungulate PrP C with a binding affinity K a of 10 8 l/mol or more; and to native ungulate PrP Sc with a binding affinity K a of 10 6 l/mol or less; and further characterized by not binding to PrP C of a mammal other than an ungulate; and

detecting the labeled antibody bound to denatured ungulate PrP Sc .

22 . A method of detecting PrP Sc in a sample, comprising the steps of:

treating a sample obtained from an ungulate to denature PrP Sc in the sample;

contacting the sample with a labeled antibody characterized by its ability to bind to denatured bovine PrP Sc and native bovine PrP C with a binding affinity K a of 10 8 l/mol or more and to native ungulate PrP Sc with a binding affinity K a of 10 6 l/mol or less; and

detecting the labeled antibody bound to denatured ungulate PrP Sc .

23 . A method of detecting PrP Sc in a sample, comprising the steps of:

treating a sample obtained from an ungulate to denature PrP Sc in the sample;

contacting the sample with a labeled antibody characterized by its ability to bind to denatured bovine PrP Sc and native bovine PrP C with a binding affinity K a of 10 8 l/mol or more and to native bovine PrP Sc with a binding affinity K a of 10 6 l/mol or less and further characterized by not binding to PrP C of a mammal other than an ungulate; and

detecting the labeled antibody bound to denatured ungulate PrP Sc .

24 . A method of detecting PrP Sc in a sample, comprising the steps of:

treating a sample obtained from an ungulate to denature PrP Sc in the sample;

contacting the sample with a labeled antibody which specifically binds to native ungulate PrP C , said antibody produced by the process comprising the steps of: synthesizing a library of antibodies on phage; panning the library against a sample by bringing the phage into contact with a composition comprising ungulate PrP proteins; isolating phage which bind native ungulate PrP C wherein the antibody is characterized by its ability to bind to denatured ungulate PrP Sc and native ungulate PrP C with a binding affinity K a of 10 8 l/mol or more and to native ungulate PrP Sc with a binding affinity K a of 10 6 l/mol or less; and analyzing the isolated phage to determine a sequence encoding an amino acid sequence to which the PrP C binds.

25 . The method of claim 24 , wherein the library of antibodies on phage are prepared by: immunizing a host mammal with PrP protein to create an immune response; extracting cells from the host mammal which cells are responsible for production of antibodies; isolating RNA from the cells of the host mammal; reverse transcribing the RNA to produce cDNA; amplifying the cDNA using a primer; and inserting the cDNA into a phage display vector such that antibodies are expressed on the phage.

26 . The method of claim 24 , wherein the process further comprises: panning antibodies against an antigen dispersed in a liposome.

27 . The method of claim 26 , wherein the antigen dispersed in a liposome is a peptide encoding an epitope of PrP C that is not available on PrP Sc .

28 . The method of claim 26 , wherein the antigen dispersed in a liposome comprises bovine residues 90-120.

29 . An assay, comprising:

a support surface; and

antibody characterized by its ability to bind to denatured ungulate PrP Sc and native ungulate PrP C with a binding affinity K a of 10 8 l/mol or more; and to native ungulate PrP Sc with a binding affinity K a of 10 6 l/mol or less; and further characterized by not binding to PrP C of a mammal other than an ungulate.

30 . The assay of claim 29 , wherein the antibody is characterized by an ability to bind 50% or more denatured ungulate PrP Sc in a liquid flowable sample.

31 . The assay of claim 29 , wherein a plurality of different antibodies are bound to the support surface and each antibody has a K a of 10 7 l/mole or more relative to PrP Sc .

32 . An assay, comprising:

a support surface; and

antibody characterized by its ability to bind to denatured bovine PrP Sc and native bovine PrP C with a binding affinity K a of 10 8 l/mol or more and to native ungulate PrP Sc with a binding affinity K a of 10 6 l/mol or less.

33 . The assay of claim 32 , wherein the antibody is characterized by an ability to bind 50% or more denatured ungulate PrP Sc in a liquid flowable sample.

34 . The assay of claim 32 , wherein a plurality of different antibodies are bound to the support surface and each antibody has a K a of 10 7 l/mole or more relative to PrP Sc .

35 . An assay, comprising:

a support surface; and

antibody characterized by its ability to bind to denatured bovine PrP Sc and native bovine PrP C with a binding affinity K a of 10 8 l/mol or more and to native bovine PrP Sc with a binding affinity K a of 10 6 l/mol or less and further characterized by not binding to PrP C of a mammal other than an ungulate.

36 . The assay of claim 35 , wherein the antibody is characterized by an ability to bind 50% or more denatured ungulate PrP Sc in a liquid flowable sample.

37 . The assay of claim 35 , wherein a plurality of different antibodies are bound to the support surface and each antibody has a K a of 10 7 l/mole or more relative to PrP Sc .

Assignments (5)
CONFIRMATORY LICENSE Recorded Mar 28, 2018
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045749/0157 →
CONFIRMATORY LICENSE Recorded Mar 19, 2018
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NIH-DEITR
Reel/Frame 045273/0247 →
CONFIRMATORY LICENSE Recorded Oct 24, 2016
From: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
To: NIH-DEITR
Reel/Frame 040100/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2006
From: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 017677/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2006
From: PRUSINER, STANLEY B.; SAFAR, JIRI; WILLIAMSON, R. ANTHONY; BURTON, DENNIS R.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 017695/0559 →